Abstract
Objective
Regulation of circulatory homeostasis is based on several factors including various circulating vasoactive substances. Whether these regulators differ between survivors and non-survivors was investigated in critically ill patients.
Design
Prospective study.
Setting
Clinical investigation on a surgical intensive care unit of an university hospital.
Patients
60 consecutive patients suffering from trauma (n=21) or postoperative complications (n=39) were studied prospectively. The patients were divided into survivors (n=27) and non-survivors (n=33). Therapy was adjusted to the standards of modern intensive care management by physicians who were not involved in the study.
Measurements and results
Endothelin-1, atrial natriuretic peptide (ANP), vasopressin, renin, and catecholamine (epinephrine, norepinephrine) plasma levels were measured from arterial blood samples using radioimmunoassay (RIA) or high-pressure liquid chromatography (HPLC) technique on the day of admission to ICU and during the following 5 days. Various hemodynamic parameters were also monitored during that period. The non-survivors showed elevated pulmonary artery pressure (PAP: 34.1±5.4 mmHg) and pulmonary capillary wedge pressure (PCWP: 20.3±7.3 mmHg) already at the beginning of the study. Cardiac index (CI) did not differ among the groups, whereas right ventricular ejection fraction (RVEF) decreased in the non-survivors. PaO2/FIO2 decreased only in the non-survivors, whereas VO2 increased in the survivors (from 246±48 to 331±43 ml/min). Plasma levels of renin (from 206±40 to 595±81 pg/ml) and vasopressin (from 5.78±0.82 to 7.97±0.69 pg/ml) increased significantly in the non-survivors. Epinephrine and norepinephrine plasma concentrations were elevated in the non-survivors already at baseline and tremendously increased in these patients during the following days. ANP plasma levels significantly increased also only in the non-survivors (from 188±63 to 339±55 pg/ml) (p<0.05). Endothelin-1 decreased in the survivors, whereas it significantly increased in the non-survivors (from 3.62±0.68 to 9.37±0.94 pg/ml) during the study period (p<0.05). Analyses of co-variance revealed overall no significant correlation between circulating vasoactive substances and hemodynamics.
Conclusions
Systemic and regional regulators of the circulation were markedly changed by critical illness. In survivors, these regulators almost normalized within the study period of 5 days, whereas in non-survivors these alterations were even aggravated. It can only be speculated whether these regulator systems were influenced by activation of various mediator systems or whether they themselves influenced the negative outcome in the non-survivors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Change history
28 July 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s00134-023-07159-9
References
Rose BD (1984) Regulation of the effective circulating volume. Rose BD (ed) Clinical physiology of acid-base and electrolyte disorders. McGraw Hill, New York, pp 171–190
Kehlet H (1984) The stress response to anaesthesia and surgery: Release mechanisms and modifying factors. Anesth Clin North Am 2:315–339
Waxman K, Shoemaker WC (1982) Physiologic responses to massive intraoperative hemorrhage. Arch Surg 117:470–475
Turnbull AV, Little RA (1993) Neurohormonal regulation after trauma. Circulating cytokines may also contribute to an activated sympathetic-adrenal control. In: Vincent JL (ed) Update in intensive care and emergency medicine. Springer, Berlin Heidelberg New York Tokyo, pp 574–581
Shoemaker WC, Appel PL, Waxman K (1982) Clinical trial of survivor's cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients. Crit Care Med 10:398–403
Quintin L, Bonnet F, Macquin I, Szekely B, Becquemin JP, Ghignone M (1990) Aortic surgery: effect of clonidine on intraoperative catecholaminergic and circulatory stability. Acta Anaesth Scand 34:132–137
Anand KJ, Hansen DD, Hickey PR (1990) Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 73:661–670
Lüscher TF (1992) Endothelin: systemic arterial and pulmonary effects of a new peptide with biologic properties. Am Rev Respir Dis 146 [Suppl 2]:S 56-S 60
Rushkoaho H, Lang RE, Toth M, Ganten D, Unger T (1987) Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J 8 (Suppl B):99–109
Needleman P, Greenwald JE (1986) Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure hemostasis. N Engl J Med 314:828–834
Underwood RD, Chan DP, Burnett JC (1991) Endothelin: an endothelium-derived vasoconstrictor peptide and its role in congestive heart failure. Heart Failure 4:50–58
Vane JR, Änggard EE, Botting RM (1990) Regulatory functions of the vascular endothelium. N Engl J Med 323:27–36
Koller J, Mair P, Wiser C, Pomaroli A, Puschendorf B, Herold M (1991) Endothelin and big endothelin concentration in injured patients. N Engl J Med 21:1518
Brenner BM, Troy JL, Ballermann B (1989) Endothelium-dependent vascular responses. J Clin Invest 84:1373–1378
Baker SP, O'Neil B (1976) The injury severity score: an update. J Trauma 16:882–888
Xuan YT, Whorton AR, Shearer-Poor E, Boyd J, Watkins WD (1989) Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun 164:326–332
Eskay R, Zukowska-Grojec Z, Haass M (1986) Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors. Science 232:636–639
Pullan PT, Clappison BH, Johnston CI (1979) Plasma vasopressin and human neurophysins in physiological and pathophysiological states associated with changes in vasopressin secretion. J Clin Endocrinol Metab 49:580–587
Thatcher R, Butty JS, Whitworth JA, Fei DT, Skinner SL (1985) Active and inactive renin in critically ill patients. Clin Exp Pharmacol Physiol 12:603–612
Krstulovic AM (1982) Investigations of catecholamine metabolism using highperformance liquid chromatography. Analytical methodology and clinical applications. J Chromatogr 229:1–34
Thijs LG (1988) Transport and consumption of oxygen in septic shock. In: Vincent JL (ed) Update in intensive care and emergency medicine, vol. 5. Springer, Berlin Heidelberg New York Tokyo, pp 44–50
Takala J, Ruokonen E (1991) Blood flow and adrenergic drugs in septic shock. In: Vincent JL (ed) Update in intensive care and emergency medicine, vol 14. Springer, Berlin Heidelberg New York Tokyo, pp 144–152
Jones SB, Romano FD (1989) Dose and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. Circ Shock 28:59–68
Hall RC, Hodge RL (1971) Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J Physiol 213:69–84
Wilson MF, Brackett DJ (1983) Release of vasoactive hormones and circulatory changes in shock. Circ Shock 11:225–234
Felicetta JV, Sowers JR (1987) Endocrine changes with critical illness. Crit Care Clin 5:855–869
Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV (1986) Multiple organ failure syndrome. Arch Surg 121:196–208
Wilson MF, Brackett DJ, Archer LT, Hinshaw LB (1980) Mechanism of impaired cardiac function by vasopressin. Ann Surg 191:494–500
Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T (1989) Plasma endothelin levels in patients with uremia. Lancet I:991–992
Athanassopoulos G, Cokkino DV (1991) Atrial natriuretic factor. Prog Cardiovasc Dis 5:313–328
Atlas SA (1986) Atrial natriuretic factor: a new hormone of cardiac origin. Recent Prog Horm Res 42:207–209
Weitzberg E, Lundberg JM, Rudehill A (1991) Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33:222–227
Goetz KL, Wang BC, Madwed JB, Zhu JI, Leadly RJ (1988) Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 55:R 1064–8
Yanagisawa M, Kurihara H, Kimura S (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 322:411–415
Rubanyi GM, Vanhoutte PM (1985) Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 364:45–56
Hartter E, Woloszczuk W (1989) Radioimmunoassay of endothelin. Lancet 1:909
Pittet JF, Morel DR, Hemsen A, Gunning, Lacroix JS, Suter PM, Lundberg JM (1991) Elevated endothelin-1 concentrations are associated with severity of illness in patients with sepsis. Ann Surg 213:261–264
Sugiura M, Inagami T, Kon V (1989) Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161:1220–1227
Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K (1993) Circulating endothelin-1 concentrations in acute respiratory failure. Chest 104:476–480
Boarder MR, Marriott DB (1989) Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J Cardiovasc Pharmacol 13 [Suppl 5]:S 223–224
Voerman HJ, Stehouwer DA, van Kamp GJ, Strack van Schijndel JM, Groeneveld J, Thijs LG (1992) Plasma endothelin levels are increased during septic shock. Crit Care Med 20: 1097–1101
Dennhardt R, Gramm HJ, Meinhold K, Voigt K (1989) Patterns of endocrine secretion during sepsis. Prog Clin Biol Res 308:751–756
Author information
Authors and Affiliations
About this article
Cite this article
Boldt, J., Menges, T., Kuhn, D. et al. RETRACTED ARTICLE: Alterations in circulating vasoactive substances in the critically ill —a comparison between survivors and non-survivors. Intensive Care Med 21, 218–225 (1995). https://doi.org/10.1007/BF01701475
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01701475